Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 396
Selected: 0
NCT IDTitle
NCT01345136Study of RAD001 for Treatment of NF2-related Vestibular Schwannoma
NCT05775471Pembrolizumab and Enfortumab Vedotin With Pembrolizumab Prior to and After Radical Nephroureterectomy for High-Risk Upper Tract Urothelial Cancer
NCT0217467968Ga DOTATATE PET/CT in Neuroendocrine Tumors (Expanded Access)
NCT00045318Exatecan Mesylate in Treating Patients With Advanced Solid Tumors and Kidney Dysfunction
NCT00066547Monoclonal Antibody Therapy in Treating Women With Locally Advanced or Metastatic Breast Cancer Previously Treated With Combination Chemotherapy
NCT00003748Irinotecan in Treating Patients With Esophageal or Stomach Cancer
NCT00004878Donor Lymphocytes to Prevent Graft-Versus-Host Disease in Patients With Chronic Myeloid Leukemia
NCT02070406Gene-Modified T Cells, Vaccine Therapy, and Ipilimumab in Treating Patients With Locally Advanced or Metastatic Malignancies
NCT02357121Focal Laser Ablation of Prostate Tissue
NCT01536743A Open Label Study of the Efficacy and Safety of PD0332991 a Selective Inhibitor of the Cyclin Dependent Kinases 4 and 6 in Patients With Recurrent Ovarian Cancer Demonstrating Rb-proficiency and Low p16 Expression
NCT04703101Short Course Radiation Therapy and Combination Chemotherapy for the Treatment of Stage II-III Rectal Cancer
NCT04473781Interstitial Brachytherapy for the Treatment of Unresectable/Unablatable Kidney Cancer
NCT06342908A Vaccine (Neoantigen-Targeted ppDC) for the Treatment of H3 G34-mutant Diffuse Hemispheric Glioma
NCT00301990Bevacizumab and Interleukin-2 in Treating Patients With Metastatic Kidney Cancer
NCT04007029Modified Immune Cells (CD19/CD20 CAR-T Cells) in Treating Patients With Recurrent or Refractory B-Cell Lymphoma or Chronic Lymphocytic Leukemia
NCT05398302Image-Guided Biopsies to Identify Mechanisms of Resistance in Patients With Metastatic Castration Resistant Prostate Cancer Treated With 177Lu-PSMA Radioligand Therapy
NCT06090630MR Correlated Spectroscopic Imaging for Diagnosing Breast Cancer
NCT01144247Cellular Immunotherapy Study for Brain Cancer
NCT00020852Cryosurgery in Treating Women With Breast Lesions
NCT02672033Accelerated Hypofractionated Radiation Therapy Immediately Before Surgery in Treating Patients With Malignant Pleural Mesothelioma
NCT00521209Patient-Directed Lifestyle Change and Health Promotion Program or Usual Care in Low-Income, Uninsured Participants in Los Angeles County, California
NCT00033514Trastuzumab and Erlotinib as First-Line Therapy in Treating Women With Metastatic Breast Cancer Associated With HER2/Neu Overexpression
NCT00093704Bortezomib and Ganciclovir in Treating Patients With Relapsed or Refractory Epstein Barr Virus-Positive Lymphoma
NCT01784640Pemetrexed Disodium and Hsp90 Inhibitor AUY922 in Treating Patients With Previously Treated Stage IV Non-Small Cell Lung Cancer
NCT00253617Stent Placement With or Without Photodynamic Therapy Using Porfimer Sodium as Palliative Treatment in Treating Patients With Stage III or Stage IV Cholangiocarcinoma That Cannot Be Removed By Surgery
NCT00054574Monoclonal Antibody Therapy in Treating Patients With Prostate Cancer
NCT02092948Phase I Study to evaluate124I-A11 PSCA Minibody in Patients With Metastatic Prostate, Bladder and Pancreatic Cancer
NCT01029925Dichloroacetate (DCA) in Patients With Previously Treated Metastatic Breast or Non-Small Cell Lung Cancer (NSCL)
NCT04429204Cryoablation for the Promotion of Local Tumor Infiltration in Patients With Mesothelioma
NCT01204684Dendritic Cell Vaccine for Patients With Brain Tumors
NCT04205838Anakinra in Preventing Severe Chimeric Antigen Receptor T-Cell Related Encephalopathy Syndrome in Patients With Recurrent or Refractory Large B-cell Lymphoma
NCT00616642Rosiglitazone in Treating Patients With Pituitary Tumors
NCT02925351Fluorine F 18 Clofarabine PET/CT in Imaging Patients With Autoimmune or Inflammatory Diseases
NCT00646633Improving Fatigue: A Pilot Study of Acupuncture and Patient Education for Breast Cancer Survivors
NCT05558904An Investigational Scan (Me-4FDG PET/CT) for the Detection of Sodium-Glucose Transport for Early Diagnosis of Lung Cancer
NCT03546361CCL21-Gene Modified Dendritic Cell Vaccine and Pembrolizumab in Treating Patients With Stage IV Non-small Cell Lung Cancer
NCT04282824Impact of Monosodium Glutamate on 68GA-PSMA-11, PET Imaging Biodistribution in Patients With Prostate Cancer
NCT00020761Irinotecan and Paclitaxel in Treating Patients With Metastatic or Recurrent Cancer of the Esophagus or Stomach
NCT00020995Low-Fat, High-Fiber Diet Compared to a Standard Diet in Treating Patients With Prostate Cancer
NCT01591577Lapatinib With Temozolomide and Regional Radiation Therapy for Patients With Newly-Diagnosed Glioblastoma Multiforme
NCT02235116Predictors of Patient Attitudes and Barriers to Skin Cancer Screening
NCT00023816Carbendazim in Treating Patients With Advanced Solid Tumors or Lymphoma
NCT05595499Fisetin to Improve Physical Function in Stage I-III Breast Cancer Survivors
NCT04457232Prospective Exploratory Study of FAPi PET/CT in Prostate Cancer With Histopathology Validation
NCT02919332Delayed 18F-FDG PET/CT in Improving Visualization of Brain Tumors in Patients With Glioblastoma
NCT02296229Stereotactic Body Radiation Therapy in Treating Patients With Localized High-Risk Prostate Cancer
NCT02826395C11 Sodium Acetate PET/CT Imaging of PCa
NCT03240861Genetically Engineered PBMC and PBSC Expressing NY-ESO-1 TCR After a Myeloablative Conditioning Regimen to Treat Patients With Advanced Cancer
NCT00685516Green Tea, Black Tea, or Water in Treating Patients With Prostate Cancer Undergoing Surgery
NCT00090909Gemcitabine, Cisplatin, and Dexamethasone in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma